Deep Brain Stimulation as a Tool for Improving Cognitive Functioning in Alzheimer’s Dementia: A Systematic Review by Katja Hardenacke et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PSYCHIATRY
REVIEW ARTICLE
published: 04 December 2013
doi: 10.3389/fpsyt.2013.00159
Deep brain stimulation as a tool for improving cognitive
functioning in Alzheimer’s dementia: a systematic review
Katja Hardenacke1, Elena Shubina1, Christian Philipp Bührle2, Alexandra Zapf 1, Doris Lenartz 2,
Joachim Klosterkötter 1,VeerleVisser-Vandewalle2 and Jens Kuhn1*
1 Department of Psychiatry and Psychotherapy, University of Cologne, Cologne, Germany
2 Department of Stereotactic and Functional Neurosurgery, University of Cologne, Cologne, Germany
Edited by:
Niels Hansen, Ruhr University
Bochum, Germany
Reviewed by:
Steve M. Gentleman, Imperial
College London, UK
Robert Friedland, University of
Louisville, USA
*Correspondence:
Jens Kuhn, Department of Psychiatry
and Psychotherapy, University of
Cologne, Kerpener Strasse 62,
Cologne 50937, Germany
e-mail: jens.kuhn@uk-koeln.de
Deep brain stimulation (DBS) is an established, in selected cases therapeutically effective,
non-lesional treatment method delivering current rectangular pulses into dysfunctional
brain structures via chronically implanted stimulation electrodes. DBS is a recognized
method applied in movement disorders and is increasingly evaluated as a possible thera-
peutic option for psychiatric diseases such as refractory obsessive-compulsive disorders,
Gilles de la Tourette syndrome, major depression, and substance-related addiction. Lat-
est research indicates that DBS may be a method for improving cognitive functions in
Alzheimer’s dementia (AD). Translational data in healthy and AD animals appear to support
this notion. Nevertheless, many aspects remain unclear, particularly with regard to the
optimal target structure. The objective of this review is to present a systematic overview
regarding published research on DBS and cognitive functioning in animal and human studies
as well as to provide a systematic overview of the feasibility and efficacy of the treatment.
We describe three studies investigating the effects of DBS in patients with dementia, using
either the fornix or the nucleus basalis of Meynert (NBM) as a target. In total, we identified
25 animal studies with 10 brain structures being targeted: fornix, NBM, anterior caudate
nucleus, dorsal striatum, anterior thalamic nucleus, midline thalamic nuclei, central thala-
mus, lateral hypothalamus, hippocampus (entorhinal cortex, perforant path), and amygdala.
Considering the wide and diverse spectrum of targets, we add to this review a supposi-
tion about possible underlying mechanisms of operation and recommendations for further
research.
Keywords: deep brain stimulation, Alzheimer’s disease, dementia, cognition, animal models, memory, target
selection
INTRODUCTION
Deep brain stimulation (DBS) is a technique affecting neuronal
discharge patterns not only locally, i.e., within the target volume,
but also in distant brain areas by conveying bioelectric impulses
along projections originating in the target volume and termi-
nating in remote structures. These projections may be uni- or
bi-directional. DBS is based on (mostly) stereotactically guided
insertion of stimulating electrodes into predefined target struc-
tures of the brain and the subsequent passing of electric pulses
through these leads for influencing neuronal viz., bioelectrical
activity there. Since its introduction in the late 1980s, chronic
DBS has substantially expanded therapeutic options in movement
disorders such as Parkinson’s disease, essential tremor, and dysto-
nia (1, 2). Some studies have shown certain encouraging results
implying DBS as a potentially effective but still highly experimen-
tal treatment modality for mental disorders. Most prominent are
the following: obsessive-compulsive disorder [OCD; with FDA-
approval under the human device exemption and also CE-mark;
Ref. (3–5)], Gilles de la Tourette syndrome (6, 7), major depression
(8, 9), or substance-related addiction (10). Based on apparently
beneficial outcomes and in view of the largely favorable actions of
DBS in addressing Parkinson’s disease, it is obvious to also discuss
DBS in the context of Alzheimer’s dementia (AD). Both clinical
entities are neurodegenerative disorders. Realizing that – despite
great efforts – a satisfactory pharmacotherapeutic breakthrough
using current strategies is still lacking, recent reports have shown
first promising preliminary results of DBS as a therapeutic tool in
patients suffering from AD, which prompted the idea of further
investigating this approach. This is supported by the fact that a
few translational studies (11) and other basic research activities
(12, 13) also may hint to a potentially neuromodulative effect of
DBS on cognition (even) in dementia. However, in all these studies
different target structures for DBS have been used. The objective
of this review is to give an overview about the currently emerg-
ing knowledge from research with regard to the usefulness of DBS
in AD.
METHODS
According to the objective of our review we searched the Pub-
Med® database for relevant publications during the last decade
(last update on 2013 May 21). By using various search terms
like “dementia,” “cognition,” “memory,” and “neurogenesis” in
combination with DBS a total of 558 results was obtained. We
screened the abstracts and included investigations, if original data
www.frontiersin.org December 2013 | Volume 4 | Article 159 | 1
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hardenacke et al. DBS targets for cognitive enhancement
were presented, the manuscript had been published in English
and referred to human or animal research in vivo. However, the
most important selection criterion was that the studies explicitly
reported the outcome of DBS treatment with the aim to mod-
ify cognitive accomplishment in demented patients. Thus, reports
were eliminated in which the level of cognitive functionality was
only assessed as a secondary outcome parameter, e.g., for exclud-
ing untoward effects. With investigations in animal models, the
search criteria were extended to studies analyzing healthy animals
for drawing long-term conclusions about the value of DBS for
alleviating cognitive deficits. After screening all relevant studies
and excluding those papers not fulfilling the inclusion criteria, we
evaluated 28 [3 human (see Table 1); 25 animal studies] studies
in further detail. These will be discussed below. Additionally, the
reference lists of the publications were screened. By doing so, five
further investigations attracted our attention [see Table 2; Ref.
(12–16)]. Since these studies do not comply with our inclusion
criteria, they were not taken into further consideration. First, we
discuss findings from human case reports and clinical investiga-
tions. Secondly, we focus on animal findings, especially taking
into account underlying hypotheses and conceivable targets. The
studies are categorized according to their target structures.
Table 1 | Studies in man investigating the effects of DBS primarily addressing cognitive performance in patients suffering from dementia.
Reference Target
structure
Patient
population
Major outcome Side effects Stimulation
parameter
Study
duration
Laxton
et al. (17)
Fornix N =6 mild to
moderate AD
Rate of cognitive decline was diminished
after DBS in these patients (assessed
with ADAS-cog and MMSE), sustained
changes in glucose metabolism
Sensation of warmth,
flushing, and sweating,
increases in heart rate
and blood pressure
3.0–3.5V 52 months
130 Hz
90µs
Fontaine
et al. (18)
Fornix N =1 mild to
moderate AD
Memory scores stabilized and
mesiotemporal lobe metabolism
increased
No 2.5V 52 months
130 Hz
210µs
Freund
et al. (19)
Nucleus basalis
of Meynert
(NBM)
N =1 Parkinson’s
dementia
Improvements in various aspects of
cognitive capacity following NBM
stimulation
No 1V 29 weeks
20 Hz
120µs
Table 2 | Studies in humans, which attract our attention and seemed to be relevant although not meeting our inclusion criteria (therefore they
are at least listed in the following table).
Reference Target
structure
Patient
population
Major outcome Side effects Stimulation
parameter
Study
duration
Fell et al.
(12)
Rhinal cortex
(RC),
hippocampus (H)
N =11 epilepsy Linear effect of stimulation condition on
memory performance (trend). Best
performance in the in-phase condition,
followed by the sham condition and the
anti-phase condition
No In mV range
40 Hz
n.a.
Anti-phase (RC
vs. H)/in-phase
(RC and H vs.
mastoid
electrode)/sham
comparison
Hamani
et al. (14)
Fornix N =1 obesitas Enhancement of autobiographic
memory
>7V: unpleasant
warming sensation, facial
hyperemia, and sweating
3V 3 weeks
130 Hz
60µs
Koubeissi
et al. (16)
Fornix N =11
intractable
epilepsy
MMSE scores showed an increase
during stimulation compared to the
baseline MMSE scores
No 8V 4 h
5 Hz
0.2µs
Stefani
et al. (15)
Pedunculopontine
tegmental
nucleus (PPTg)
N =6 morbus
Parkinson
Increase of regional cerebral glucose
metabolism (rCMRgI). Significant
improvement of different cognitive
functions
No 2.4V
25 Hz
60µs
52 months
Suthana
et al. (13)
Entorhinal cortex
(EC)
N =7 pharmaco-
resistant
epilepsy
Enhancement of spatial memory
performance. Resetting of the theta
rhythm (EEG)
No Up to 3.0V ON/OFF
comparison50 Hz
300µs
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HUMAN STUDIES
At the time of this writing, studies about the impact of DBS on
memory and cognition in dementia are still quite rare. There is one
case report [nucleus basalis of Meynert (NBM); Ref. (19)] and two
feasibility studies [2× fornix; Ref. (17, 18)] investigating the effects
of DBS on cognitive functions in Parkinson’s and AD respectively.
FORNIX STIMULATION
In 2008, a single case report on the effect of hypothalamic/fornix
DBS for the treatment of obesity was published by Hamani et al.
(14). A 50-year-old man was exposed to bilateral (ventral) chronic
hypothalamic/fornix DBS for 3 weeks. However, the primary ther-
apeutic objective of counteracting morbid obesity was a failure.
Nonetheless, remarkable stimulation effects upon the modifica-
tion of memory processes were observed incidentally. During
intraoperative acute stimulation (pulse amplitude: 3.0 V, pulse
width: 60µs, and frequency 130 Hz), the patient reported sudden
“dejà vu” – feelings, e.g., seeing himself in a situation 20 years ago.
This artificially evoked autobiographical memory became more
vivid when stimulation intensity was increased from 3.0 to 5.0 V.
With increasing stimulation voltage still further (≥7 V), markedly
stronger adverse effects, including the perception of an unpleasant
generalized warming sensation, followed by facial hyperemia and
sweating, were experienced. Neuropsychological testing at 2.8 V
demonstrated an increase in recollection assessments at baseline
before surgery as well as 3 and 52 weeks after continuous bilateral
stimulation in a recognition task. This may suggest hypothala-
mic involvement in memory function. The authors concluded
that hypothalamic/fornix DBS apparently influences bioelectric
activity in limbic areas, thus exerting hippocampus-dependent
memory-enhancing effects.
Based on that case report, this group started an open-label
phase-I study (17). Here, six patients with mild and early AD were
treated with bilateral fornix stimulation for 12 months. Electrodes
were placed 2 mm anterior and parallel to the vertical portion
of the fornix. Two weeks after surgery, chronic stimulation was
commenced (amplitude: 3.0–3.5 V; pulse width: 90µs; frequency:
130 Hz). Like surgery itself, this was well tolerated. Stimulation set-
tings and pharmacotherapy (cholinesterase inhibitors) remained
constant for 12 months, while extensive clinical and neuropsycho-
logical assessments were done 1, 6, and 12 months post-surgery.
Clinical evaluation – using the Alzheimer’s Disease Assessment
Scale [ADAS-cog; Ref. (20)] as the primary outcome criterion –
suggested some post-surgical improvement, particularly in verbal
recollection. However, the results of the ADAS-cog were variable
among individual patients. A decelerated progression of cogni-
tive decline was claimed and seemed to be reflected by the scores
of the Mini Mental Status Examination [MMSE; Ref. (21)] indi-
cated by a rate of decrease of 2.8 points preceding DBS, com-
pared to a rate of decline of 0.8 points after surgery. Sustained
alterations in cerebral glucose metabolism were also observed in
frontal-temporal-parietal-striatal-thalamic and frontal-temporal-
parietal-occipital-hippocampal networks after 1 year of DBS. A
higher baseline metabolism and shifts in glucose utilization after
1 year coincided with improved clinical outcomes in cognition,
memory, and quality of life (22). EEG-based analysis, such as stan-
dardized low resolution electromagnetic tomography, sLORETA
(23), 6 and 12 months after the implantation of the electrodes
showed that DBS apparently promotes neural activity in mem-
ory circuits including the entorhinal and hippocampal area thus
modulating the default mode network. This network is character-
ized by coherent neural oscillations below 0.1 Hz, being activated
during passive task states such as remembering or daydreaming
(24). Taken together, these results suggest that neural activity in
memory-relevant circuitry (involving fornix-hippocampal path-
ways) might be altered by fornix DBS, especially in entorhinal
and hippocampal brain regions. As an interesting byline concern-
ing potential future studies, the authors proposed that there is
a relationship between disease severity and efficiency of fornix
DBS. Patients with better pre-stimulation cognitive functional-
ity are more likely to benefit from DBS than are patients with
advanced AD. This hypothesis was supported by the observation
that higher preoperative glucose metabolism apparently correlated
with improved clinical outcome as far as cognitive functions and
quality of life measures are concerned (22). Along these lines, it
has been speculated that in individuals with mild and early AD
functional integrity of the fornix-hippocampus circuit might still
be intact, thus increasing the chances for a beneficial response
to DBS. The authors asserted that it is the dysfunctional default
mode network that should be subjected to stimulation instead of
a specific target region in order to stabilize cognitive functioning.
Although this investigation provides indications that fornix
stimulation might have memory-enhancing effects, extreme cau-
tion should be exercised when interpreting these results as a con-
sequence of the open-label design, the small number of patients,
and the absence of a control group (25).
A further study focusing on the feasibility and safety of DBS
in AD was recently published by Fontaine et al. (18). In this
investigation, 110 patients with established AD or mild cognitive
impairment (MCI) were screened; of these, nine patients met the
inclusion criteria of being below the age of 70 and having only a
mild cognitive deficit with impairments predominantly involving
episodic memory. However, only one patient agreed to participate
in this investigation and to undergo surgery. The patient was stim-
ulated bilaterally in the hypothalamus, with the target being in
close proximity to the fornix. The exact location of the electrode
was 2 mm anterior and parallel to the vertical portion of the fornix
within the hypothalamus. The stimulus amplitude was 2.5 V with
a frequency of 130 Hz and a pulse width of 210µs. No compli-
cations were reported, and surgery was well tolerated. Prior to
DBS, deficits were identified particularly well in episodic memory.
Clinical and neuropsychological assessments were done 3 months
and 1 week before surgery, as well as 3, 6, and 12 months thereafter.
Results showed that memory scores (e.g., MMSE, ADAS-cog) were
stabile after 1 year of continuous stimulation by contrast to con-
trol conditions, but nevertheless remained well below pre-surgical
assessments. A subjective feeling of improvement was expressed by
the patient herself. No significant changes were observed regard-
ing behavior or mood and nor regarding PET results 1 year after
surgery. However, the glucose metabolism was slightly improved
in medial temporal lobes, which is not typical for the sponta-
neous evolution of the disease. Nevertheless, the results should
be interpreted with utmost reserve, since only one patient was
studied.
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NUCLEUS BASALIS OF MEYNERT STIMULATION
A unique feature in the course of both AD and Parkinson’s demen-
tia (PDD) is basal forebrain degeneration including the latter’s
cholinergic projections to the cortex. Neurostimulation of ascend-
ing basal forebrain projections of the NBM may, therefore, rep-
resent a new strategy for enhancing the residual nucleus basalis
output. The relevance of the cholinergic forebrain for brain plas-
ticity has, for instance, been illustrated by the reshaping of auditory
receptive fields during and after stimulation of the NBM in the
adult brain (26).
Based on this notion [for further details, see Ref. (19, 27)] we
implanted in a patient with PDD – additionally to the nucleus
subthalamicus (STN) electrodes to treat the motor symptoms –
bilateral electrodes into the NBM (laterodorsal portion of the
intermediate part) and implemented low-frequency DBS (20 Hz),
intending to evoke excitatory effects of the residual NBM output.
DBS of the STN was done using standard 130 Hz stimulation for
evoking beneficial motor effects. Neuropsychological assessments
including memory evaluation were performed 1 week prior to the
operation and after surgery using different combinations of stim-
ulation configurations: STN stimulation only, combined STN and
NBM stimulation, and STN stimulation with NBM sham stimula-
tion. Apparently, cognitive functions remained largely unaffected
by electrical stimulation of the STN, whereas cognitive functions
improved markedly with additional bilateral stimulation of NBM.
In particular, partial functions such as attention, concentration,
alertness, drive, and spontaneity were noticeably enhanced and, as
a consequence,an improvement in mood and enjoyment of former
activities was observed in the patient. Additionally, ideational and
ideomotor apraxic symptoms were positively influenced following
NBM stimulation [Ref. (28); for more information]1. Electros-
timulation of the STN combined with sham stimulation of the
NBM resulted in a marked deterioration of cognitive functions.
One day after restarting NBM stimulation, a significant improve-
ment in cognitive functionality was observed, and memory scores
returned to the performance levels seen in the beginning of the
combined bilateral stimulation. Based on this case report, we initi-
ated a phase-I investigation with six patients with mild to moderate
AD who were treated with DBS of the NBM (unpublished data)2.
TRANSLATIONAL STUDIES
With research in humans, the currently available database is
extremely small and limited in scope, since only very few AD
patients have been systematically treated with DBS so far. In order
to augment the available data on DBS in humans and its effective-
ness regarding cognition as well as to further support the notion
that DBS might be an effective method to augment cognitive func-
tioning in dementia, we also included animal data into this review.
A total of 25 studies focusing on DBS-induced influences on
memory, cognition, and/or neurogenesis were scrutinized. In vitro
studies were only included when they referred to behavioral obser-
vations. In animal experimentation, DBS was studied in 10 brain
regions: fornix, NBM, anterior caudate nucleus, dorsal striatum
1http://onlinelibrary.wiley.com/doi/10.1002/mds.23141/suppinfo
2http://clinicaltrials.gov/ct2/show/NCT01094145?term$=$DBS$+
$Alzheimer&rank$=$2; in review
(DS), anterior thalamic nucleus (AN), midline thalamic nuclei
(MTN), central thalamus (CT), lateral hypothalamus (LH), hip-
pocampus enthorinal cortex (EC, perforant path), and amygdala.
In analogy to the human data, we subsequently categorized the
animal studies according to their targets.
FORNIX STIMULATION
One way to create an experimental model for memory deple-
tion is to mimic memory impairment and cholinergic deficit
by injecting rats with scopolamine, a muscarinic acetylcholine
(ACh) receptor antagonist, inducing a blockade of ACh recep-
tors in the hippocampus (29). Such a model was used in rats for
evaluating DBS effects in the forniceal region on memory func-
tion (30). All animals were injected with scopolamine prior to
behavioral testing. The stimulated animals performed much bet-
ter than the sham-stimulated group. The authors asserted that
memory enhancement was achieved by driving the fornix activ-
ity both orthodromically and antidromically by stimulating large
myelinated axons. These results are illustrating the importance
of the connection between hippocampus and AN as well as the
antagonizing DBS effect on scopolamine receptor blockade in the
hippocampus. No DBS-induced side effects on motor activity or
anxiety level were observed.
NUCLEUS BASALIS MAGNOCELLULARIS/OF MEYNERT STIMULATION
Some effects of NBM DBS on memory acquisition, consolidation,
and content retrieval were investigated in rats (31). Stimulation
(1 Hz, 100µA) was able to improve memory acquisition possibly
by involvement of early memory encoding and/or maintenance.
Several suppositions are put forth by the authors: DBS might have
enhanced ACh release from NBM neurons that in turn favor-
ably influenced neural plasticity mechanisms and/or increased
attention and the state of readiness. Further, the amygdala, a struc-
ture that is relevant to aversively motivated learning, could have
been activated, leading to modulation of memory consolidation in
other brain regions. Besides, GABAergic projections to the cortex
could have interplayed with NBM cholinergic neurons to produce
cortical plasticity (31).
Once again, NBM stimulation-induced facilitation of mem-
ory acquisition was observed in rats (32). Unilateral stimulation
(100µA, 1 Hz) before behavioral training resulted in enhanced
memory acquisition when compared to DBS outside the NBM
or to unstimulated animals. Expression of c-Fos, an early gene
protein product, was increased by NBM DBS bilaterally in pre-
frontal cortical areas (orbitofrontal, prelimbic, and infralimbic
cortices) and some hippocampal subregions [dorsal CA (cornu
ammonis region) and ventral dentate gyrus (DG)]. The authors
suggested that DBS-induced memory improvement was likely due
to enhanced neural activity of brain structures related to the
memory system.
Hotta et al. observed an increase in extracellular neuron growth
factor (NGF) in rats due to electrical stimulation (50 Hz, 200µA)
of the NBM as measured by an immunosorbent assay (33, 34). This
increase was sustained for hours after stopping the stimulation
and was probably the result of an enhanced NGF-mRNA expres-
sion. Nicotinic (mecamylamine), but not muscarinic (atropine)
ACh receptor antagonists abolished this NGF response (34). The
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authors argued that DBS-induced NBM activation might help to
maintain neuronal plasticity and might have a protective effect on
the cerebral cortex as well. However, the enhancement of ipsilat-
eral NGF release was observed in adult, but not in aged rats (34).
The authors claimed that NGF release in adult rats was mediated
by nicotinic cholinergic inputs from the NBM to the cortex, which
is reduced or absent in aged rats.
NUCLEUS CAUDATUS STIMULATION
Stimulation of the anterior caudate in rhesus monkeys allegedly
improved learning by enhancing the acquisition of selective visuo-
motor associations (35). Here, the monkeys had to associate
images with a specific movement by trial and error. High frequency
stimulation (HFS; 200 Hz, 200µA) during correct responses
improved the initial performance, whereas stimulation during
failed trials only impaired the learning process. Stimulation of the
rostral putamen or low frequency stimulation (LFS; 20 Hz) did not
influence learning performance. The authors proposed a direct
involvement of the caudate in augmenting selective visuomotor
associations during learning, probably at reinforcement time.
DORSAL STRIATUM STIMULATION
An adverse effect of unilateral left DS DBS was observed on mem-
ory in rats (36). Stimulation did not affect learning performance,
but seemed to impair procedural memory (defined by chosen
strategies during the task). GABA (but neither 5-HT, 5-HIAA,
dopamine, DOPAC, HVA nor glutamate) neurotransmitter level
was increased 19 h after DBS bilaterally in the DS. It can be
supposed, that this long-term or delayed DBS effect on striatal
GABAergic system could lead to a stronger inhibition of neuronal
and synaptic activity thereby explaining the impairment in pro-
cedural memory. Another given explanation could be a left-right
functional imbalance of neural activity due to unilateral stimu-
lation. As the GABA level was increased bilaterally, the authors
speculated that left and right DS interact either via corticostriatal
fibers and their antidromic activation or via substantia nigra and
the thalamus (36).
ANTERIOR NUCLEUS OF THE THALAMUS STIMULATION
The anterior nucleus of the thalamus (AN) is one target region
for DBS in epilepsy (37). Because the AN is assumed to be part
of the memory circuit, Hamani et al. addressed the question if
unilateral AN DBS in rats modulates memory performance [130
or 20 Hz; Ref. (38)]. High-current (500µA) DBS impaired mem-
ory acquisition, whereas neither consolidation nor retrieval was
influenced.
Brain slices of previously stimulated (bilaterally, 130 Hz,
500µA) rats showed increased c-Fos expression in the regions
connected to AN (cingulate cortex, orbitofrontal cortex, and lat-
eral EC), implying that AN DBS might influence structures at
a distance from the target as well. According to the authors,
this indicates that AN DBS not just inhibits AN cells but could
still drive local axonal fibers and influence further structures like
the hippocampal formation. In fact, in vivo electrophysiological
recordings revealed a reduced firing rate of gyrus dentate cells
after high-current stimulation [500µA; Ref. (38)].
By contrast, other studies reported beneficial effects of AN DBS
on memory and neurogenesis. These discrepancies might originate
from different time frames and general conditions of stimulation,
e.g., the widely differing stimulation parameters and unknown
pulse shapes. The initial impairment of memory performance after
stimulation might be just transient and would subside with pos-
sibly induced plastic changes, leading to memory improvement
when training is conducted at longer intervals (39). In this context
the observed neurogenesis induced by DBS in the following three
studies (39–41) is quite interesting.
In a study of Toda et al. AN stimulation was performed bilat-
erally for 1 h using variable frequencies [10, 50, 130 Hz; 2.5 V; Ref.
(40)]. Already 3 h after stimulation AN activity was increased in
stimulated rats compared to controls (as revealed by zif268, an
early growth response protein, immunostaining). Cell prolifera-
tion was observed (via BrdU, that incorporates into new generated
DNA, immunostaining) several days after and was two- to three-
fold increased 3 and 5 days after DBS in granule cell layer and
subgranular zone of DG. At long-term (31 days after DBS) 46%
of the newly generated cells were characterized as mature neu-
rons (NeuN-positive; neuronal marker), while 7% were astrocytes
(GFAP-positive; astrocyte marker), indicating that a large per-
centage of DBS-induced newborn cells of the DG develops into
mature neurons without significantly altering the proportion of
differentiating cell types.
In addition, HFS restored the effect of corticosterone, a sup-
pressor of hippocampal neurogenesis (39, 40) in rats. Already
1 day after corticosterone injection the number of newborn cells
was reduced by about 68.3% compared to vehicle treatment (40).
In stimulated animals, due to counteraction of DBS on corti-
costerone, the cell number was only reduced by 23.2%. Similar
observations were made after longer periods (28 days) with only
about a third reduction of newborn cells due to the counteract-
ing DBS effect. Further, the long-term effect of this counteraction
was evident on behavioral level as well since the corticosterone-
dependent impaired performance was reversed by DBS (39). This
effect was attributed by the authors to neuroplastic changes that
are surmised to require a considerable time to become structurally
and functionally effective. Consistent with this, an increased hip-
pocampal proliferation was observed in stimulated animals (BrdU
immunostaining). The long delay between stimulation and behav-
ioral testing could have assured a more proceeded functional
maturation of newborn DG cells and hence a better memory
performance.
Similar findings as to neurogenesis were also reported for
mice (41). Thereby, HFS (130 Hz) selectively increased symmetric
divisions of amplifying neural progenitors (ANPs; by 81% over
unstimulated animals), and not the division of quiescent neural
progenitors. ANPs evolve into migrating postmitotic precursors
that slowly mature into granule neurons of DG. Hence, their divi-
sion may be the key step in regulating neurogenesis. After HFS the
number of matured neurons in the granular layer was increased
by 53% (vs. non-stimulation). Stimulation of the frontal asso-
ciative area of the cortex did not reveal differences between LFS
and HFS, indicating that only HFS of the limbic circuit is able
to produce such changes. These findings apparently support the
assertion of an excitation-driven neurogenesis and consequen-
tial improvement in memory performance. However, it is far
from clear, whether electrostimulation actually is able to promote
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neurogenesis. Since the general design of such experiments is fre-
quently rather unclear, and the immunohistochemical methods
used are far from specific and therefore hardly suitable to prove
a causal relationship between DBS and neogenesis of operational
neurons, these results and assertions should be viewed with all due
caution.
MIDLINE THALAMIC NUCLEI STIMULATION
Arrieta-Cruz et al. used a transgenic mouse model of AD
(TgCRND8 mice, Tg, characterized by reduction in overall CA1
basal synaptic transmission) to evaluate the actions of DBS
in MTN on short-term memory (42). Prior to DBS (25 Hz,
300µA), the Tg mice revealed worse memory acquisition and
short-term memory than the wild type (WT), whereas contin-
uous DBS was able to improve the behavioral performance of
the Tg mice. To study proper synaptic transmission prior to
the onset of pathological amyloid deposition, hippocampal slices
from young mice were used for electrophysiological recordings
in vitro. For instance, Schaffer collateral projections from the
CA3 region were stimulated (10–100µA) to activate CA1 neu-
rons [for details, see Ref. (42)]. Synaptic transmission and plas-
ticity in the Tg group was reduced compared to controls. The
authors concluded that a synaptic dysfunction in the hippocam-
pus might subsequently lead to progressive memory and learn-
ing impairment. Whereas short-term potentiation in WT was
observed already after stimulation trains at 50 and 100 Hz, Tg
mice showed this effect just at 200 Hz, suggesting that neurons
in Tg mice are less excitable. Increased neuronal activity in DG
and CA1 region induced by stimulation was confirmed by FosB
staining. In addition, stimulation-induced synaptic changes led
to the increase of α-secretase activity in CA1 (42). α-Secretase
cleaves the APP at Aβ peptide sites and subsequently inhibits
the generation of Aβ peptides, which are associated with the
development of AD. Hence, these findings suggest that HFS
enhances synaptic plasticity and memory performance and might
modulate Aβ accumulation in the brain in a mouse model
of AD.
CENTRAL THALAMUS (CT) STIMULATION
Unilateral HFS (100 Hz, 1.5 mA) of the central lateral (CL) nucleus
of the anterior intralaminar thalamus in rats led to transsynaptic
activation of CL neurons and upregulation of immediate-early
genes (c-Fos and zif268) in the motor cortex, anterior cingulate
cortex, caudate-putamen, and hippocampus (43). This was asso-
ciated with a prompt and daily growing memory improvement.
Furthermore, the motor activity was increased through DBS as
well, indicating generalized arousal, which could be responsible
for the increased cognitive performance.
Influences of DBS in bilateral rostral intralaminar thalamic
nuclei were examined in rats (44). Application of low currents
(0.01 mA) enhanced memory performance whereas higher cur-
rents (0.1 or 1 mA) impaired it, demonstrating an inverted-U rela-
tionship between thalamic activity and behavioral performance
(44). The rostral intralaminar nucleus of the thalamus seems to
play an important part particularly in retrieval and facilitating
memory-guided responding which in turn could be enhanced by
low current stimulation.
Improvement of behavioral performance was achieved by DBS
(50 Hz, 200–500µA) in the CT of two macaque monkeys (45).
Although, according to the authors, this improvement was likely
due to increased arousal state.
Shah et al. performed DBS (130 Hz, 1.8–8 mA) in the CT
in a macaque monkey (46). The high variability in the results
[increased (3/32), decreased (1/32), mixed (14/32), or no effect
(14/32) on behavior] following DBS revealed a high complexity of
CT stimulation on arousal, behavior, and cognition.
LATERAL HYPOTHALAMUS AND AMYGDALA STIMULATION
Segura-Torres and colleagues investigated whether post-training
intracranial self-stimulation (ICSS), a form of DBS in which ani-
mals are electrically stimulated when pressing a lever, may facilitate
explicit memory in rats (47, 48). Rats were implanted unilaterally
with an electrode at the LH, into the fibers of the medial forebrain
bundle, and were taught to self-stimulate by pressing a lever in a
Skinner box (50 Hz, 10–250µA).
When declarative/relational learning was required, the ICSS
group performed better than non-stimulated group. Thus, the
ICSS could have enhanced (hippocampus dependent) declara-
tive or relational learning (47). Further, with intense training,
both groups performed similarly, whereas with little training the
amplifying group performed better than the non-stimulated group
implicating the former achieved a reliable level of explicit mem-
ory (48). The authors proposed that (post-training) ICSS is more
effective when morphological and physiological changes involved
in memory consolidation are not fully matured as in case of little
training.
In another investigation, memory retrieval was facilitated only
at long-term (24 h after) and not immediately after the ICSS, indi-
cating a time dependent effect of ICSS on memory retrieval (49).
However, there was no difference between the ICSS group and
animals with intermediate training sessions, suggesting that the
ICSS effect on learning could be the same as additional training.
Whether the main effect of ICSS was proactive, retroactive, or both
remained unclear. Nevertheless, a strong long-term facilitation of
memory retrieval was suggested by the authors (49).
In another experiment, the rats completed a single five-trial ses-
sion and subsequently were exposed to ICSS (50). The retention-
level was higher in the ICSS group at a retention time of 24 h and
especially 48 h (not at 72 h) compared to controls. No modulating
effects on performance were observed after ICSS before training,
thus the authors suggested a retroactive ICSS effect on the consol-
idation process of previous learning. Additionally, the long-term
ICSS effect was tested 7 days after the 48 h retention session. The
further behavioral improvement of ICSS animals was smaller than
in previous sessions and also smaller than the improvement of
the control group. Though, the overall performance of the ICSS
group was better compared to controls, suggesting that the effect
of the ICSS treatment was sustained (50). This finding indicates
memory facilitation induced by post-training ICSS by affecting
the consolidation of (brief) previous learning.
Segura-Torres and colleagues studied the effects of LH ICSS on
hippocampal (51) and amygdalar (52) gene expression (90 min
and/or 4.5 h after ICSS). c-Fos immunolabeling revealed increased
activity in the amygdala, pyramidal layer (CA3), and granule cell
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layer (DGmb and DGlb). The hippocampal cell labeling varied
in intensity, signifying that ICSS leads to activation of gene tran-
scription in distinct cells (51). In spite of unilateral stimulation,
the neurochemical effects were predominantly bilateral. In both
stimulated regions, hippocampus and amygdala, increased expres-
sion of COX-2 gene which is related to neurite outgrowth and
neurogenesis was observed (51, 52). Furthermore, genes related
to protein folding (Hspa1a), neurite outgrowth and neurogenesis
(Ret), neuroprotection (Hspa1a, Ret, Dnajb1), and anti-apoptosis
(Hspa1a, Ret, Dnajb1, Fkbp5) were upregulated in both regions.
Increased BDNF and Arc gene expression which is believed to be
related to synaptic plasticity, was observed in the amygdala, but not
examined in the hippocampus. Expression of even more genes was
induced in the hippocampus by LH ICSS, which was not affected
(e.g., Sgk, Pde1a) or not evaluated (e.g., Ubqln1) in the amygdala.
In total, the expression of 62 early genes was influenced in the
hippocampus by ICSS. Fifty-one percentage of the 37 expressed
genes that encode proteins of known or presumed functions, may
directly or indirectly promote learning and memory or neuropro-
tection (51). Recently, the research group additionally observed
increased expression of early gene proteins, c-Fos and Nurr1 (tran-
scription factor expressed in dopamine cells) due to stimulation
(53). The changes in gene expression were predominantly ipsi-
lateral [for details, see Ref. (53)]. The c-Fos enhancement (with
and without conditioning) was observed in almost all parts of
brain regions studied (amygdala, hippocampus, DS, lateral hip-
pocampus). By contrast, no enhancement in Nurr1 expression
was observed in the amygdala. This rising was measured 70 min,
but not 48 h after stimulation suggesting a rapid and transient
increase in expression. In some hippocampal regions, acquisi-
tion of behavioral testing alone was able to facilitate expression
of these early genes. However, the combination with ICSS had a
greater effect. In some regions it seemed like the test acquisition
(+ICSS) could not additionally affect the gene expression in LH
compared to ICSS alone. The authors concluded that c-Fos and
Nurr1 mediate the facilitative effects of ICSS on memory consol-
idation. Further they proposed that the observed upregulation in
genes involved in neurogenesis could indirectly facilitate learn-
ing and memory: the newly generated cells could be protected
by products from upregulated genes related to neuroprotection,
which could protect preexistent neurons as well. As an example,
the authors took the gene Ubqln1 which is related to the regu-
lation of protein degradation and may reduce protein aggregates
and their toxicity. Such protein aggregates are known from AD and
these findings give a possible approach to prevention of aggrega-
tion through DBS. Overall, these studies demonstrated that ICSS
modulates hippocampal and amygdal activity and the regulation
of gene expression,which differs between these regions. Thus, ICSS
may facilitate learning and memory by enhancing cellular and
molecular mechanisms related to neuroplasticity, neurogenesis,
and neuroprotection (51, 52).
HIPPOCAMPUS, EC, AND PERFORANT PATH STIMULATION
Concerning neurogenesis, similar findings as with DBS in AN (39–
41) were made by Stone et al. while investigating the outcome of
acute uni- or bi-lateral stimulation (130 Hz, 0–500µA) in the EC
in mice (11). Activity in the granular cell layer of the middle and
posterior regions of the ipsilateral DG increased following unilat-
eral EC stimulation at low current density (50µA, 30–120 min),
inferred by c-Fos staining. The number of proliferating cells in the
ipsilateral DG was transiently increased, especially in the granular
cell layer of the middle and posterior regions of the ipsilateral DG.
As in the study of Toda et al. maximum increase was observed
about 3–5 days after stimulation. Increase in stimulation dura-
tion from 30 to 60 min was coincident with higher proliferation
rates, whereas increasing stimulation duration to 120 min did not
result in any gain. Stimulation increased the differentiation into
neurons and had a modest pro-survival effect on existing nerve
cells. Cell characteristics (rate of neuronal differentiation, local-
ization, morphology, afferent and efferent connections, long-term
survival) were comparable to nerve cells generated under control
conditions. According to the authors these results imply that the
new neurons integrated into hippocampal circuitry. The behav-
ioral performance was improved when the animals had training
6 weeks – rather than 1 week – after DBS (unilateral and bilateral),
when the new neurons were fully matured and integrated into the
memory circuits, as proposed by the authors. The facilitated spa-
tial learning and memory retrieval coincided with an increased
number of activated neurons in stimulated animals compared
to unstimulated controls (11). If the mice were pretreated with
agents known to inhibit neurogenesis (e.g., the DNA-alkylating
agent temozolomide), both proliferation as well as spatial mem-
ory performance were reduced in all mice, but to a higher extent
in the unstimulated subgroup. According to the authors, this con-
firms that the improved cognitive effects originated, at least in part,
as a result of stimulation-promoted hippocampal neurogenesis.
McCartney et al. demonstrated in rats that HFS (200 Hz) of the
perforant path, a connection from the EC to all fields of the hip-
pocampus formation, triggers theta phase resetting and the release
of ACh, an alleged prerequisite for creating conditions favoring
long-term potentiation [LTP; Ref. (40, 54)]. The authors specu-
late that HFS probably disrupted the circuits involved in encoding
and retrieving stimuli information in the working memory task.
Subsequently, theta phase resetting was believed to be associated
with short-term encoding and retrieval and not only to long-term
memory formation. Apparently, it can be speculated that theta
resetting might synchronize incoming stimuli with hippocampal
circuits with the aim of ensuring favorable conditions regarding
the facilitation of encoding of the information into memory.
DISCUSSION
We reviewed the literature of the last decade and presented an
overview of human and animal studies investigating the effects of
DBS on cognitive functions with the primary aim to assess the
potential of using DBS in the therapy of dementia. The avail-
able clinical evidence in human case studies comprises only a
total of three investigations. The primary intent was to enhance
cognitive functions in patients with dementia utilizing through
DBS (17–19). [We identified five further potentially interesting
studies dealing with the effects of DBS on several cognitive func-
tions in other patient groups (13–16); because of not fulfilling our
inclusion criteria they are only mentioned in Table 2.]
Considering the average low complication rate in a cohort
of approximately 100,000 Parkinson patients treated with DBS
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globally (55, 56) DBS seems to be a feasible and safe treatment
for patients with dementia. Independently of the target struc-
ture being stimulated, patients recovered quickly from surgery
and only rarely experienced cognitive deterioration caused by the
intervention.
Judging from an extremely small number of cases, the fornix is
currently the target most frequently chosen for treating dementia
(one phase-I study and one feasibility study). Generally, chronic
stimulation was well tolerated, except for sensations of warmth,
flushing, and sweating as well as increases in heart rate and blood
pressure at higher stimulus voltages (>7 V) in two studies (14, 17).
The neuropsychological results were highly variable both in valid-
ity and content, but might be interpreted with considerable reserve
as indicating a stabilization of the disease progression after surgery,
although there are no hard facts supporting this as yet. The stimu-
lation parameters in both studies are similar with respect to voltage
(2.5–3.5 V) and frequency (130 Hz). Pulse width varied between 60
and 90µs. Although, taken at face value, these results may be seen
as encouraging, they are still rather ambiguous. As a consequence,
these observations may be spurious and should therefore be con-
templated with all due caution. This is particularly true, when the
episodic nature of the findings and the extremely small number of
cases, defying proper statistical treatment, are factored in (N = 6
and N = 1). This is aggravated by the fact that only open-label
designs were used and by the lack of a control groups. Support-
ing the idea of the fornix being an acceptable target structure, we
gave an account of a study investigating the acute effects of DBS
of the fornix on specific cognitive performances in patients with
intractable epilepsy. This report alleged improved neuropsycho-
logical scores assessed with the MMSE during stimulation (16).
However, the stimulation parameters were different compared to
the fornix DBS studies in dementia, with higher voltages (8 V), LFS
(5 Hz), and narrow pulse width (0.2µs). They are therefore not
comparable. Hence, the majority of the pivotal questions raised in
this context still remain unanswered.
Support for such a tentative approach may be derived from a
single animal study (30) which ascribed improved memory perfor-
mance to fornix DBS (measured by means of the object location
task) in rats, which had received an injection of scopolamine, a
muscarinic ACh receptor antagonist, allegedly causing a blockade
of ACh receptors in the hippocampus and thus mimicking some
aspects of AD. Fornix DBS was reported to reverse the scopolamine
action.
As to a further potential target structure, there is one investi-
gation dealing with the effects of low-frequency (20 Hz) DBS in
the NBM for treating a patient with PDD, stressing patient safety,
and technical feasibility of this method and also auspicious results
regarding memory and other cognitive realms, such as attention,
visual processing, or practical symptoms (19). Data of a phase-I
investigation with six patients with mild to moderate AD treated
with DBS in the NBM are currently under review (see text foot-
note 2). In three animal studies (31, 33, 34) NBM DBS indicated
an improvement in memory performance. It was claimed that,
as a result of ACh release from the NBM, attention, and state
of readiness are enhanced and neuroplastic mechanisms may be
influenced positively. Additionally, NGF secretion was increased
throughout the entire cortex, possibly mediated by its nicotinic
cholinergic inputs from the NBM. The authors also alleged that
memory improvement may be associated with an increased c-Fos
expression in the stimulated brain regions; this claim, however,
should be contested on the basis of possibly flawed reasoning. In
a recent review of Gratwicke et al. the potential of the Nucleus
basalis Meynert as a target for DBS in dementia was emphasized
by characterizing the anatomy, intrinsic organization, and connec-
tivity of the cholinergic nucleus. The authors believe that especially
the afferent and efferent projections of the NBM, the 90% cholin-
ergic neurons, and the early degeneration in AD make the Nucleus
basalis Meynert a promising target structure in dementia (57).
Taking into account the results of both human and animal stud-
ies which are still rather scant and hard to interpret correctly, the
NBM seems to be an auspicious target when it comes to future
evaluations of its suitability as a structure to be stimulated for
alleviating cognitive deficits in dementia.
Other potential DBS targets which might warrant evaluation
in patients with dementia are the entorhinal cortex (13) and
the pedunculopontine tegmental nucleus (15), because at least in
some areas of cognition such as spatial orientation (EC), executive
functions, and attention (PPTg), slight improvements appeared to
occur in humans. Animal studies support the potential of the EC
as a target for DBS. Stimulating the EC in mice, the neogenesis of
neurons transiently increased and a modest pro-survival effect on
existing cells could be observed (11).
Similarly, it was shown in rodents that electrical stimulation of
the perforant pathway, a route connecting the entorhinal cortex
to virtually all fields of the hippocampal formation, may trig-
ger a theta phase resetting, thereby possibly creating favorable
conditions for long-term potentiation. These results may con-
firm the hypothesis that resetting theta activity probably facilitates
the potentiation and encoding of relevant incoming stimuli (54).
There was no translational data available investigating the effects
of stimulation of the PPTg.
In addition to the experimental investigations already alluded
to, further translational studies were found in the literature which
assessed effects on cognition after electrically stimulating brain
regions for which data in humans are still lacking. The follow-
ing structures are involved here: LH, central thalamus, amygdala,
anterior nucleus of the thalamus, DS, nucleus caudatus, midline
thalamic region, and perforant pathway of the hippocampus.
Lateral hypothalamus DBS was accomplished via ICSS, a
method based on the activation of the reward system. Con-
sequently, ICSS enhancement of memory and cognition may,
however, just be the result of evoking unspecific neural arousal.
However, such a facilitation was observed in a multitude of experi-
ments (47–51, 53) and was, for instance, associated with enhanced
expression of genes related to memory, cognition, neurogenesis,
and neuroprotection. This would turn LH into an interesting target
for DBS. Similar enhancement of gene expression was observed in
a single study of amygdala ICSS (52). Nevertheless, further inves-
tigations are required, before any reasonable conclusions may be
drawn.
The stimulation effects in CT were quite inconsistent and
appeared to depend even more critically on the stimulation para-
meters compared with DBS in other targets (43–46). Here, the
choice of stimulation parameters was demonstrated to be essential
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for discerning between improvement and impairment of cognition
(44). A generalized and unspecific arousal is most likely responsible
for improved memory performance, although CT DBS-induced
activation of immediate-early genes could be a promising indi-
cation for a potential target structure which would merit further
exploration.
Several animal studies claim that excitation-associated cell pro-
liferation and hippocampal neurogenesis may be traced back
to AN DBS, implicating the target as very interesting (39–41).
Reported outcomes pertaining to influence general memory per-
formance by AN stimulation are rather contradictory (38, 41),
which probably is due to different stimulation parameters. This
should be thoroughly clarified in further investigations, especially
since in some studies flawed or inappropriate methodology, but
also biased reasoning cannot be excluded.
Deep brain stimulation in the DS allegedly impaired memory
performance in a single observation (36). This clearly does not
suffice for a meaningful evaluation of this target structure and,
consequentially, asks for further investigation.
Single translational studies reported on improved memory per-
formance after DBS in the nucleus caudatus (35) and in the midline
thalamic region (42), with the latter using an AD mouse model.
Moreover, in the transgenic mouse,α-secretase activity in the CA1
region increased after DBS and thus might affect Aβ accumulation
in AD. Accordingly, this effect should be observed in future related
investigations.
Unfortunately, translational research of DBS is severely limited
in many respects, making extrapolation of the results obtained
and the conclusions drawn precarious if not epistemologically
impossible when the situation in the much more complex and
intricate human brain is concerned. This may be exemplified as fol-
lows: in contrast to clinical treatment, only acute and short-lasting
stimulation (minutes to days) was used in most animal studies
referred to here, likely resulting in decreased or even completely
different effects. In many animal experiments, the investigation
of the actions of neurostimulation was frequently done only a
short time after the onset of the stimulation. It is evident that this
time frame is much too short for detecting possible neuroplas-
tic changes which require periods ranging from days to several
months to develop and stabilize. It goes without saying that this
holds especially in cases, where changes in the hard-wiring of
neuronal circuitry are involved.
The animal experiments presented in this review were notori-
ous for their extreme variability as far as stimulation parameters
are concerned (pulse amplitude, duration, frequency, polarity,
monopolar or bipolar, and shape, monophasic or biphasic). In
addition, electrode geometry, material as well as area and shape of
contacts are mostly unknown, resulting in ill-defined and vastly
different current densities in the respective targets. Given the
nearly infinite amount of possible permutations of the classical
stimulus parameters, the odds for attaining comparable results in
rats and humans are very small. Adding differences in electrode
geometry, contact configuration, electrode material which may be
polarizable or non-polarizable (Ag/AgCl2), the notion that – at the
present stage of affairs – any results from rodent experimentation
may be transferred to the situation in humans would verge on
wishful thinking.
An equally severe conundrum lies with the fact that the effects
of intracranial depth stimulation in experimental studies almost
exclusively were observed in naïve animals not actually suffering
from dementia, therefore lacking the structural damages as well as
the pathophysiology typically underlying dementia. Accordingly, it
would be a grave misconception, if an attempt was made to extrap-
olate experimental results obtained, for instance, in essentially
healthy rodents to patients suffering from a chronically progres-
sive neurodegenerative disease like AD (58). It also fundamentally
confounds the concept of “translational research”that the majority
of the investigations quoted here used adult but not aged ani-
mals which do not match the average age of the affected patient
group.
Many transgenic and non-transgenic animal models with Aβ
and/or tau pathology are used for the study of AD [for a review,
see Ref. (59)]. Implementation of such models in DBS-related
investigations may increase the information value (face, predic-
tive, and construct) of this kind of experimentation, since more
supporting evidence for possible mechanisms underlying the still
elusive mode of action of DBS on memory in dementia might
emerge.
Nevertheless, successfully translating data and conclusions
drawn from phylogenetically rather primitive animals to humans
without meticulous planning at all stages to most closely and faith-
fully model the situation obtaining in actual dementia patients
appears to be an exercise in futility.
However, studies investigating the mode of action of DBS
on cognition in healthy subjects would probably provide cer-
tain clues concerning its functionality in patients suffering from
dementia. In conclusion, the investigated studies – human and
animal research – indicated that the facilitating effect of DBS is
most likely a markedly multi-factorial phenomenon comprising a
host of vastly different mechanisms from nearly every field cov-
ered by the basic sciences. Apart from classical neurophysiology
and neuroanatomy also genetics, neurochemistry, cybernetics, and
non-linear dynamics including the theory of coupled oscillators,
i.e., mathematical physics as well as linear and non-linear systems
theory, are involved here.
Taking this into account, continuing clinical research efforts
as well as animal experimentation addressing DBS efficiency
in future treatment of dementias with a neurodegenerative
basis such as Alzheimer’s disease appear to be worthwhile.
Only the future will show whether this approach is a success-
ful one.
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